Literature DB >> 31534832

Peripartum Cardiomyopathy: A Review.

Lindsay C Ballard1, Adrian Cois2, Bory Kea3.   

Abstract

PURPOSE OF REVIEW: Peripartum cardiomyopathy (PPCM) is an important condition with high morbidity and mortality worldwide. Patients with PPCM are at risk of developing life-long cardiac disease, requiring regular management and medical intervention. This article conducts a review of recent literature and gives insight into this disease. RECENT
FINDINGS: There is promising research in the fields of vascular, hormonal and genetics. A number of genetic markers are being analyzed; including TTNC1, TTN and STAT3. Mutations to these genes have been found to be prevalent in PPCM. These combined with the secretion of placental angiogenic factors potentially create imbalance in angiogenesis as the primary etiology.
SUMMARY: Current biomarkers do not differentiate between PPCM and other variants of heart failure. Women with PPCM are more likely to have a cesarean section, have hypertensive disease, at greater risk of major adverse cardiac events and to have lifelong morbidity.

Entities:  

Keywords:  cardiomyopathies; heart failure; peripartum cardiomyopathy; preeclampsia; pregnancy

Year:  2019        PMID: 31534832      PMCID: PMC6750803          DOI: 10.1007/s40138-019-00192-3

Source DB:  PubMed          Journal:  Curr Emerg Hosp Med Rep        ISSN: 2167-4884


  52 in total

1.  Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy.

Authors:  U Elkayam; P P Tummala; K Rao; M W Akhter; I S Karaalp; O R Wani; A Hameed; I Gviazda; A Shotan
Journal:  N Engl J Med       Date:  2001-05-24       Impact factor: 91.245

2.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.

Authors:  Clyde W Yancy; Mariell Jessup; Biykem Bozkurt; Javed Butler; Donald E Casey; Mark H Drazner; Gregg C Fonarow; Stephen A Geraci; Tamara Horwich; James L Januzzi; Maryl R Johnson; Edward K Kasper; Wayne C Levy; Frederick A Masoudi; Patrick E McBride; John J V McMurray; Judith E Mitchell; Pamela N Peterson; Barbara Riegel; Flora Sam; Lynne W Stevenson; W H Wilson Tang; Emily J Tsai; Bruce L Wilkoff
Journal:  Circulation       Date:  2013-06-05       Impact factor: 29.690

3.  A microRNA links prolactin to peripartum cardiomyopathy.

Authors:  Ying Yang; Jessica E Rodriguez; Richard N Kitsis
Journal:  J Clin Invest       Date:  2013-04-24       Impact factor: 14.808

4.  High prevalence of viral genomes and inflammation in peripartum cardiomyopathy.

Authors:  Burkhard D Bültmann; Karin Klingel; Michael Näbauer; Diethelm Wallwiener; Reinhard Kandolf
Journal:  Am J Obstet Gynecol       Date:  2005-08       Impact factor: 8.661

5.  Frequency of peripartum cardiomyopathy.

Authors:  Lisa M Mielniczuk; Kathryn Williams; Darryl R Davis; Anthony S L Tang; Robert Lemery; Martin S Green; Michael H Gollob; Haissam Haddad; David H Birnie
Journal:  Am J Cardiol       Date:  2006-04-21       Impact factor: 2.778

6.  Peripartum cardiomyopathy: population-based birth prevalence and 7-year mortality.

Authors:  Margaret A Harper; Robert E Meyer; Cynthia J Berg
Journal:  Obstet Gynecol       Date:  2012-11       Impact factor: 7.661

7.  Differences in clinical profile of African-American women with peripartum cardiomyopathy in the United States.

Authors:  Sorel Goland; Kalgi Modi; Parta Hatamizadeh; Uri Elkayam
Journal:  J Card Fail       Date:  2013-04       Impact factor: 5.712

8.  MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy.

Authors:  Julie Halkein; Sebastien P Tabruyn; Melanie Ricke-Hoch; Arash Haghikia; Ngoc-Quynh-Nhu Nguyen; Michaela Scherr; Karolien Castermans; Ludovic Malvaux; Vincent Lambert; Marc Thiry; Karen Sliwa; Agnes Noel; Joseph A Martial; Denise Hilfiker-Kleiner; Ingrid Struman
Journal:  J Clin Invest       Date:  2013-04-24       Impact factor: 14.808

9.  A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy.

Authors:  Denise Hilfiker-Kleiner; Karol Kaminski; Edith Podewski; Tomasz Bonda; Arnd Schaefer; Karen Sliwa; Olaf Forster; Anja Quint; Ulf Landmesser; Carola Doerries; Maren Luchtefeld; Valeria Poli; Michael D Schneider; Jean-Luc Balligand; Fanny Desjardins; Aftab Ansari; Ingrid Struman; Ngoc Q N Nguyen; Nils H Zschemisch; Gunnar Klein; Gerd Heusch; Rainer Schulz; Andres Hilfiker; Helmut Drexler
Journal:  Cell       Date:  2007-02-09       Impact factor: 41.582

10.  Cardiac angiogenic imbalance leads to peripartum cardiomyopathy.

Authors:  Ian S Patten; Sarosh Rana; Sajid Shahul; Glenn C Rowe; Cholsoon Jang; Laura Liu; Michele R Hacker; Julie S Rhee; John Mitchell; Feroze Mahmood; Philip Hess; Caitlin Farrell; Nicole Koulisis; Eliyahu V Khankin; Suzanne D Burke; Igor Tudorache; Johann Bauersachs; Federica del Monte; Denise Hilfiker-Kleiner; S Ananth Karumanchi; Zoltan Arany
Journal:  Nature       Date:  2012-05-09       Impact factor: 49.962

View more
  1 in total

Review 1.  Mitochondrial Function and Dysfunction in Dilated Cardiomyopathy.

Authors:  Daniela Ramaccini; Vanessa Montoya-Uribe; Femke J Aan; Lorenzo Modesti; Yaiza Potes; Mariusz R Wieckowski; Irena Krga; Marija Glibetić; Paolo Pinton; Carlotta Giorgi; Michelle L Matter
Journal:  Front Cell Dev Biol       Date:  2021-01-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.